Evidence map›Paper›PMID 34489961›Full record

ReviewFrontiers in immunology2021

Promising Technologies in the Field of Helminth Vaccines.

Dilhan J Perera, Momar Ndao

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Dilhan J PereraDivision of Experimental Medicine, McGill University, Montreal, QC, Canada.
Momar NdaoDivision of Experimental Medicine, McGill University, Montreal, QC, Canada.
McGill University · CAMcGill University Health Centre · CA

Funding

CIHR FBD-175968
6 · The paper itself

Abstract

Helminths contribute a larger global burden of disease than both malaria and tuberculosis. These eukaryotes have caused human infections since before our earliest recorded history (i.e.: earlier than 1200 B.C. for

Indexed as

InventionsVaccinesAdjuvants, ImmunologicAnimalsAntigens, HelminthClinical Trials as TopicHelminthiasisHelminthsHumansImmunogenicity, VaccineMiceNucleic Acid-Based VaccinesTh2 CellsVaccinationVaccine DevelopmentVaccine EfficacyAdjuvants, ImmunologicAntigens, HelminthNucleic Acid-Based VaccinesVaccinesVaccines, AttenuatedVaccines, SubunitVaccines, Syntheticadjuvanthelminthnext generation vaccinenext generation vaccinologynucleic acid vaccinerecombinant protein vaccinevaccineviral vector

Identifiers

PMID34489961
PMCPMC8418310
OpenAlexW3194128433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.